Skip to Main Content

Author Archives: O’Neill Institute

05.06.21

Lessons from One of the World’s Most Successful, Yet Unusual, COVID-19 Vaccination Campaigns

By O’Neill Institute

This expert column was written by Kashish Aneja and Nishtha Arora. As of April 8, 2021, the Ministry of Health of the Royal Kingdom of Bhutan reported having administered the first doses of COVID-19 vaccines to almost 93% of its eligible adult population. 85% of its eligible adult population was vaccinated within the first week […]

Tags:

04.15.21

The Promise and Peril of Vaccine Passports

By O’Neill Institute

This expert column was written by Anastasia Vernikou and Katherine Ginsbach. As the rollout of COVID-19 vaccines has progressed, countries have begun to look for ways to lift restrictive public health measures, like lockdowns. This has amplified the discussion around the effectiveness and potential challenges of vaccine certificates, or passports. Showing proof of vaccination record […]

Tags:

03.09.21

Better Masks Offer Better Protection Against COVID-19 Variants. Governments Should Act Quickly.

By O’Neill Institute

This expert column was written by Katherine Ginsbach and Anastasia Vernikou.  SARS-CoV-2 is mutating. More than a year into the COVID-19 epidemic, virus mutations are increasing transmission rates, compounding the opportunities to transform further. Given the ever-expanding risk to population health, governments must continuously monitor the efficacy of current public health regulations, making needed updates […]

Tags:

01.19.21

Most U.S. Health Plans Must Now Cover the Full Cost of PrEP, But More Than the Medication Is Needed for HIV Prevention

By O’Neill Institute

This expert column was written by Landon Myers and Sean Bland. Pre-exposure prophylaxis, or PrEP, is a medication that people at risk for HIV take to prevent HIV acquisition. When taken as prescribed, it is highly effective for preventing HIV acquisition. Despite its efficacy, PrEP uptake has been relatively low in the United States, in […]

Tags:
Thematic Areas: Infectious Diseases

01.14.21

India Must Have Vaccine Transparency for the World’s Largest Immunization Program to Succeed

By O’Neill Institute

This expert column was written by Kashish Aneja.  On January 16, India is set to launch the world’s largest national immunization programme with two of its ‘made in India’ vaccines. India sits at the center of the COVID-19 response, not just because it has the second-highest number of global cases, or only due to its […]

Tags:

12.08.20

A New Roadmap for Supporting American Families

By O’Neill Institute

This expert column was written by John T. Monahan.  Even with the prospect of new COVID-19 vaccines in 2021, it is clear the pandemic has battered, and continues to threaten, the economic and social foundations on which most Americans have built and sustained their lives. The impact of the coronavirus will almost certainly worsen over […]

Tags:

12.03.20

What Should Food Banks Do When Demand Outpaces Supply in Emergencies?

By O’Neill Institute

This expert column was written by Sarah Wetter and James G. Hodge, Jr.  For millions of Americans this holiday season, the most critical line they face is not for COVID-19 testing, vaccines, or unemployment benefits, but rather the long wait at food banks and pantries across the country. As the toll of the pandemic worsens, […]

Tags:
Thematic Areas: Health & Human Rights

12.01.20

Could a Systems Approach be the Disruptor Needed in HIV Prevention?

By O’Neill Institute

This expert column was written by Charles Holmes, Sara M. Allinder, and Anna Carter.   Business as usual is not working in HIV prevention. The latest UNAIDS data from 2019 demonstrates that we are collectively failing to bring down the number of new infections globally. Despite tremendous gains in the number of people living with HIV […]

Tags:

11.12.20

Medication-Based Treatment for Substance Use Disorder in Correctional Facilities: Critical Components Missing from MOUD Legislation

By O’Neill Institute

This expert column was written by Madelyn O’Kelley-Bangsberg. Over the last several years, there has been increased attention to establishing adequate withdrawal and treatment protocols for persons with substance use disorders in jails and prisons. Advocates are trying to increase the availability of medication for opioid use disorder (MOUD) within correctional facilities by bringing litigation […]

Tags:
Thematic Areas: Addiction & Public Policy

11.10.20

Medication-Based Treatment for Substance Use Disorder in Correctional Facilities: Factors Influencing the Enactment of Legislation

By O’Neill Institute

This expert column was written by Madelyn O’Kelley-Bangsberg. Across the country, correctional institutions are implementing medication for opioid use disorder (MOUD) programs in jails and prisons to save lives and money. However, barriers to further expansion of MOUD programs persist, including stigma and immediate costs. In 2018, only 1% of jails and prisons in the […]

Tags:
Thematic Areas: Addiction & Public Policy

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.